Home › Funds › Sofinnova Investments, Inc. › BMRN

Sofinnova Investments, Inc. position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Sofinnova Investments, Inc. reported holding 432,695 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$26.0M, representing 1.17% of its reported portfolio and ranking #22 among its reported holdings. Sofinnova Investments, Inc. has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)432.69K sh
Reported value held$25.96M
Portfolio Weight1.17%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s BMRN position evolved

Sofinnova Investments, Inc. first disclosed a stake in BMRN in Q4 2025 at 697,133 shares (US$41.4M). The position peaked in Q1 2026 at 781,982 shares, worth US$44.2M. Across 4 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 432,695 shares valued at US$26.0M — an increase of 74,127 shares quarter over quarter.. Notable position changes include a 54% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 697.13K $41.43M New
Q1 2026 781.98K $44.17M Add
Q2 2026 358.57K $20.52M Reduce
Q3 2026 432.69K $25.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Sofinnova Investments, Inc. held BMRN?

Sofinnova Investments, Inc. has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Sofinnova Investments, Inc.'s current position in BMRN?

As of Q3 2026, Sofinnova Investments, Inc. holds 432.69K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $25.96M, representing 1.17% of its reported portfolio and ranking #22.

Has Sofinnova Investments, Inc. been buying or selling BMRN?

In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. increased its position in BMRN. The position peaked in Q1 2026 at 781.98K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.